UNICREDIT BANK/CALL/NOVO-NORDISK B/800/0.1/18.09.24 Share Price

Warrant

DE000HC9M3Z3

Real-time BOERSE MUENCHEN 09:15:48 05/07/2024 pm IST
2.48 EUR +2.48% Intraday chart for UNICREDIT BANK/CALL/NOVO-NORDISK B/800/0.1/18.09.24
Current month-15.38%
1 month+9.01%
Date Price Change
05/24/05 2.48 +2.48%
04/24/04 2.42 +7.56%
03/24/03 2.25 -16.04%
02/24/02 2.68 -7.90%
01/24/01 2.91 +1.75%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 09:15 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer UniCredit UniCredit
WKN HC9M3Z
ISINDE000HC9M3Z3
Date issued 02/10/2023
Strike 800 kr
Maturity 18/09/2024 (75 Days)
Parity 10 : 1
Emission price 0.56
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.15
Lowest since issue 0.45
Delta0x
Omega 0.000000
Premium0x
Gearing5.23x
Moneyness 1.218
Difference Strike -174 kr
Difference Strike %-21.75%
Spread 0.07
Spread %2.77%
Intrinsic value 2.330
Present value 0.1746

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
970 DKK
Average target price
952.2 DKK
Spread / Average Target
-1.84%
Consensus